Market in Focus: Surgical Sealants and Glues
Executive Summary
Over the past few decades, the wound closure market has seen the introduction of a number of new technologies, including a variety of surgical adhesives and glues for both external and internal use to hold tissues together and/or reinforce surgical suture or staple lines. These products address a market that encompasses over 73 million surgical wounds annually in the US alone and generated sales of over $367 million in the US last year, according to Medtech Insight's recently published report US Markets for Current and Emerging Wound Closure Technologies. The US market for surgical sealants and glues is growing at an annual rate of about 3.8% and is expected to reach about $443 million in sales by 2013.
You may also be interested in...
Baxter Spends Big on ApaTech to Join Orthobiologics Fray
Baxter International Inc. brought its full and considerable weight to bear to the orthobiologics market by paying handsomely for Apatech Inc., a privately held start-up with a silicate substituted calcium phosphate synthetic bone graft material.
Baxter Spends Big on ApaTech to Join Orthobiologics Fray
Baxter International Inc. brought its full and considerable weight to bear to the orthobiologics market by paying handsomely for Apatech Inc., a privately held start-up with a silicate substituted calcium phosphate synthetic bone graft material.
Targeting Acute Wounds with Advanced Technologies
Acute wound care will continue to evolve as hospitals face increasing pressure from payors and patient safety advocates to address the issue of surgical wounds and surgical site infections. CMS has added SSIs to the list of preventable, hospital-acquired conditions that it will no longer cover. A number of companies are seizing the opportunity to develop technologies that can help hospitals and patients avoid these costly conditions.